Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 210 (RNA5SP210)

Target
RNA5SP210
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 210 (RNA5SP210) is a processed non-coding RNA pseudogene located in the human genome[2][4][6]. It is a sequence homologous to the functional 5S ribosomal RNA gene but has lost the ability to encode a functional RNA due to disabling mutations or truncations[8]. 5S rRNA is a component of the large ribosomal subunit in functional form, but pseudogenes such as RNA5SP210 are traditionally considered “junk DNA” and are generally not transcribed or translated into active products[3][8]. However, some processed rRNA pseudogenes may occasionally be transcribed, with rare cases suggesting regulatory roles in specific disease contexts (e.g., interferon regulation in alcohol-associated hepatitis[10]), but this is not generalizable or well established for RNA5SP210 specifically. As such, RNA5SP210 is not a therapeutic target, does not encode a druggable enzyme, protein, or receptor, and does not have known pharmacological or biomarker relevance[2][4][6][8]. Key points: - This entry describes a pseudogene of the 5S ribosomal RNA, not a functional gene, protein, or receptor, and thus does not qualify as a therapeutic target. - Genomic annotation pipelines (such as GENCODE and Ensembl) list RNA5SP210 as an rRNA pseudogene, and it does not play a known direct role in cellular biology nor does it interact with drugs or serve as a biomarker[2][4][6][8]. - As a pseudogene, there is inherent ambiguity regarding its function, but based on available data, there is no evidence for a canonical, clinically relevant role[2][8].

Other names
RNA5SP210RN5S210RNA, 5S ribosomal 210RNA, 5S ribosomal pseudogene 210
02

Biological functions

None (pseudogene; lacks intrinsic biological function of the parent 5S rRNA; however, rare instances of regulatory function reported in some pseudogenes)
03

Disease associations

Other (as a pseudogene, there is no established, consistent disease association; limited evidence of 5S rRNA pseudogene transcripts being involved in immunity and interferon regulation in specific contexts)

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 210 (RNA5SP210).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 210 (RNA5SP210).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call